Hwu P - Search Results

1

Clinicopathological features and clinical outcomes associated with TP53 and BRAF^N^on-^V⁶⁰⁰ mutations in cutaneous melanoma patients.

Kim DW, Haydu LE, Joon AY, Bassett RL Jr, Siroy AE, Tetzlaff MT, Routbort MJ, Amaria RN, Wargo JA, McQuade JL, Kemnade J, Hwu P, Woodman SE, Roszik J, Kim KB, Gershenwald JE, Lazar AJ, Davies MA. Kim DW, et al. Among authors: hwu p. Cancer. 2017 Apr 15;123(8):1372-1381. doi: 10.1002/cncr.30463. Epub 2016 Dec 2. Cancer. 2017. PMID: 27911979 Free PMC article.

2

Dendritic cells strongly boost the antitumor activity of adoptively transferred T cells in vivo.

Lou Y, Wang G, Lizée G, Kim GJ, Finkelstein SE, Feng C, Restifo NP, Hwu P. Lou Y, et al. Among authors: hwu p. Cancer Res. 2004 Sep 15;64(18):6783-90. doi: 10.1158/0008-5472.CAN-04-1621. Cancer Res. 2004. PMID: 15374997 Free PMC article.

3

A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma.

Ballo MT, Zagars GK, Gershenwald JE, Lee JE, Mansfield PF, Kim KB, Camacho LH, Hwu P, Ross MI. Ballo MT, et al. Among authors: hwu p. Ann Surg Oncol. 2004 Dec;11(12):1079-84. doi: 10.1245/ASO.2004.12.039. Ann Surg Oncol. 2004. PMID: 15576833

4

Combined-modality therapy for patients with regional nodal metastases from melanoma.

Ballo MT, Ross MI, Cormier JN, Myers JN, Lee JE, Gershenwald JE, Hwu P, Zagars GK. Ballo MT, et al. Among authors: hwu p. Int J Radiat Oncol Biol Phys. 2006 Jan 1;64(1):106-13. doi: 10.1016/j.ijrobp.2005.06.030. Epub 2005 Sep 22. Int J Radiat Oncol Biol Phys. 2006. PMID: 16182463

5

Immunosuppression in melanoma immunotherapy: potential opportunities for intervention.

Lizée G, Radvanyi LG, Overwijk WW, Hwu P. Lizée G, et al. Among authors: hwu p. Clin Cancer Res. 2006 Apr 1;12(7 Pt 2):2359s-2365s. doi: 10.1158/1078-0432.CCR-05-2537. Clin Cancer Res. 2006. PMID: 16609059 Review.

6

Systemic therapy for unresectable metastatic melanoma: impact of biochemotherapy on long-term survival.

Bedikian AY, Johnson MM, Warneke CL, McIntyre S, Papadopoulos N, Hwu WJ, Kim K, Hwu P. Bedikian AY, et al. Among authors: hwu wj, hwu p. J Immunotoxicol. 2008 Apr;5(2):201-7. doi: 10.1080/15476910802131519. J Immunotoxicol. 2008. PMID: 18569391 Free article.

7

Prognostic factors that determine the long-term survival of patients with unresectable metastatic melanoma.

Bedikian AY, Johnson MM, Warneke CL, Papadopoulos NE, Kim K, Hwu WJ, McIntyre S, Hwu P. Bedikian AY, et al. Among authors: hwu wj, hwu p. Cancer Invest. 2008 Jul;26(6):624-33. doi: 10.1080/07357900802027073. Cancer Invest. 2008. PMID: 18584354

8

Changes in pERK1/2 and pAKT expression in melanoma lesions after imatinib treatment.

Hwang CS, Prieto VG, Diwan AH, Lizee G, Ellerhorst JA, Ekmekcioglu S, Liu P, Eton O, Kinney SA, Grimm EA, Hwu P, Kim KB. Hwang CS, et al. Among authors: hwu p. Melanoma Res. 2008 Aug;18(4):241-5. doi: 10.1097/CMR.0b013e3283046146. Melanoma Res. 2008. PMID: 18626307 Free PMC article. Clinical Trial.

9

Biochemotherapy in patients with advanced head and neck mucosal melanoma.

Bartell HL, Bedikian AY, Papadopoulos NE, Dett TK, Ballo MT, Myers JN, Hwu P, Kim KB. Bartell HL, et al. Among authors: hwu p. Head Neck. 2008 Dec;30(12):1592-8. doi: 10.1002/hed.20910. Head Neck. 2008. PMID: 18798304

10

Complete response of stage IV anal mucosal melanoma expressing KIT Val560Asp to the multikinase inhibitor sorafenib.

Quintás-Cardama A, Lazar AJ, Woodman SE, Kim K, Ross M, Hwu P. Quintás-Cardama A, et al. Among authors: hwu p. Nat Clin Pract Oncol. 2008 Dec;5(12):737-40. doi: 10.1038/ncponc1251. Epub 2008 Oct 21. Nat Clin Pract Oncol. 2008. PMID: 18936790

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

389 results

Search Page

Filters